Finally, this case underscores a critical research gap and highlights the urgent need for multicenter registries to better define the natural history of PCP and develop more sensitive, context‐specific prognostic tools, potentially incorporating dynamic biomarkers like IL‐6 or procalcitonin. This evidence concerns the gene IL6 and pneumocystosis.